Business Description

Description
Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.
Name Current Vs Industry Vs History
Cash-To-Debt 0.02
Equity-to-Asset -1.63
Debt-to-Equity -1.48
Debt-to-EBITDA -1.14
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.21
Quick Ratio 0.21
Cash Ratio 0.04

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -125.2
Shareholder Yield % -285.88
Name Current Vs Industry Vs History
ROE % -476.87
ROA % -130.37
ROIC % -28.78
ROC (Joel Greenblatt) % -1850.12
ROCE % -299.65

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -1.29
EV-to-EBITDA -1.3
EV-to-FCF -8.07
Earnings Yield (Greenblatt) % -77.52
FCF Yield % -83.97

Financials

BNZPF's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with GREY:BNZPF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Biosenic Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) 0.04
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 4.2
12-1 Month Momentum % 0
52-Week Range ($) 4.2 - 4.2
Shares Outstanding (Mil) 125.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biosenic Filings

Filing Date Document Date Form
No Filing Data

Biosenic Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Biosenic Frequently Asked Questions

What is Biosenic(BNZPF)'s stock price today?
The current price of BNZPF is $4.20. The 52 week high of BNZPF is $4.20 and 52 week low is $4.20.
When is next earnings date of Biosenic(BNZPF)?
The next earnings date of Biosenic(BNZPF) is .
Does Biosenic(BNZPF) pay dividends? If so, how much?
Biosenic(BNZPF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1